HMS
Hanseatic Management Services’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,559
| Closed | -$545K | – | 131 |
|
|
2022
Q4 | $545K | Buy |
+4,559
| New | +$545K | 1.38% | 16 |
|
|
2020
Q1 | – | Sell |
-9,047
| Closed | -$972K | – | 247 |
|
|
2019
Q4 | $972K | Buy |
+9,047
| New | +$972K | 0.89% | 32 |
|
|
2018
Q4 | – | Sell |
-10,507
| Closed | -$1.29M | – | 313 |
|
|
2018
Q3 | $1.29M | Sell |
10,507
-2,407
| -19% | -$296K | 1.2% | 17 |
|
|
2018
Q2 | $1.27M | Buy |
12,914
+462
| +4% | +$45.4K | 1.09% | 21 |
|
|
2018
Q1 | $1.03M | Buy |
12,452
+21
| +0.2% | +$1.74K | 0.99% | 25 |
|
|
2017
Q4 | $965K | Buy |
+12,431
| New | +$965K | 0.97% | 30 |
|
|
2016
Q1 | – | Sell |
-35,752
| Closed | -$2.02M | – | 289 |
|
|
2015
Q4 | $2.02M | Sell |
35,752
-147
| -0.4% | -$8.31K | 0.7% | 51 |
|
|
2015
Q3 | $1.43M | Buy |
35,899
+17,563
| +96% | +$699K | 0.44% | 88 |
|
|
2015
Q2 | $876K | Buy |
18,336
+4,716
| +35% | +$225K | 0.39% | 96 |
|
|
2015
Q1 | $541K | Buy |
+13,620
| New | +$541K | 0.29% | 96 |
|
|
2013
Q3 | – | Sell |
-3,778
| Closed | -$51K | – | 267 |
|
|
2013
Q2 | $51K | Buy |
+3,778
| New | +$51K | 0.03% | 123 |
|